Nova NVMI · NASDAQ
$311.35 +0.39% (+$1.22)
Summary
68 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 29 USD is left as net profit.
- Earnings per share grew by 22% a year over the last 3 years.
- Analysts expect revenue to grow by 22% this fiscal year.
What to watch
- The share price is above the Bulios Fair Price.
- Revenue growth is slowing: 16% a year over the last 3 years against 27% over 5 years.
- It passes only 3 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 37.5 USD for 1 USD of yearly profit. Over the last five years it was 34.8 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 27% a year over 5 years. Over the last 3 years it grew by 16% a year. For the next fiscal year analysts expect revenue to grow by 22%. Earnings per share grew by 22% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 43 USD
- Research and development 16 USD
- Sales and administration 12 USD
- Taxes and other 0.1 USD
- Net profit 29 USD
Net profit, industry median (Semiconductors) 11 USD
Out of every 100 USD of revenue, 29 USD is left as net profit.
Profitability in detailIs it financially healthy?
YesRepaying all its debt would take 4.2 years of free cash flow. It holds more cash than debt.
Financial health in detailDoes it pay a dividend?
NoIt pays no dividend.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 12
- Hold 2
- Sell 0
Today's price within the analysts' price targets
The average target of $556.5 is 79% above today's price. 86% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
Fiscal year 2025By product
- Product 100%
By region
The company reports no revenue by region.
Product brings in 100% of revenue.
Segments in detail